Skip to main content
. Author manuscript; available in PMC: 2022 May 25.
Published in final edited form as: J Adolesc Health. 2021 Oct 7;69(6):976–982. doi: 10.1016/j.jadohealth.2021.08.020

Table 1.

Participant demographics (n = 103)

Age, mean (standard deviation) 43 (9.4)
n (%)
Gender identitya
 Cisgender women 65 (63)
 Cisgender men 22 (21)
 Trans men 2 (2)
 Nonbinary or genderqueer 4 (4)
Race/ethnicitya
 Non-Hispanic white 72 (70)
 Non-Hispanic Asian 5 (5)
 Non-Hispanic black 2 (2)
 Non-Hispanic Middle Eastern, North 2 (2)
 African, Arab, or Chaldean
 Hispanic or Latinx 4 (4)
 Biracial or other 7 (7)
Current occupation
 Doctor (MD/DO) 100 (97)
 Nurse practitioner 2 (2)
 Physician’s assistant 1 (1)
Primary trainingb
 Pediatrics 54 (52)
 Adolescent medicine 39 (38)
 Endocrinology 32 (31)
 Family medicine 10 (10)
 Other 6 (6)
Census region where providers practiceb
 Midwest 40 (39)
 Northeast 57 (55)
 South 51 (50)
 West 52 (50)
Gender-affirming care providedb
 Prescribed hormones 96 (93)
 Prescribed menstrual suppressants 91 (88)
 Prescribed antiandrogens 89 (86)
 Surgery referrals 88 (85)
 Prescribed puberty blockers 83 (81)
 Letter writing to support medical care 81 (79)
 Mental healthcare 18 (17)
Time providing gender-affirming care to TGDYa
 <1 year 4 (4)
 1–3 years 23 (22)
 4–6 years 35 (34)
 7–9 years 22 (21)
 10–19 years 15 (15)
 20+ years 3 (3)
Number of TGDY patientsa
 <5 2 (2)
 5–10 12 (12)
 11–50 29 (28)
 51–100 16 (16)
 101–150 10 (10)
 151–200 8 (8)
 201+ 25 (24)

TGDY = transgender and gender diverse youth.

a

Note all responses were optional, therefore some categories do not total to 100%.

b

Greater than total n as participants are able to choose more than one option.